Abstract
Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Current Pharmacogenomics
Title: Pathway-based Approaches to Pharmacogenomics
Volume: 5 Issue: 1
Author(s): C. F. Thorn, M. Whirl-Carrillo, T. E. Klein and R. B. Altman
Affiliation:
Keywords: HumanCyc pathway, STKE Connections, CYP gene, GenMAPP, Systems Biology Mark-Up Language
Abstract: Researchers are using pathway information for both pharmacogenomics study design and data analysis. Candidate gene approaches for the design of pharmacogenomic studies need reliable pathway information to choose the best candidate genes and SNPs, especially when using low to medium throughput genotyping technologies, to maximize the likelihood of success. With the mainstream use of high throughput gene expression microarrays and genome wide SNP assays, pathway-based approaches can also be valuable tool for data analysis. This review will discuss sources of pathway data and mechanisms for applying it to pharmacogenomics research.
Export Options
About this article
Cite this article as:
Thorn F. C., Whirl-Carrillo M., Klein E. T. and Altman B. R., Pathway-based Approaches to Pharmacogenomics, Current Pharmacogenomics 2007; 5 (1) . https://dx.doi.org/10.2174/157016007780077167
DOI https://dx.doi.org/10.2174/157016007780077167 |
Print ISSN 1570-1603 |
Publisher Name Bentham Science Publisher |
Online ISSN 1570-1603 |
Related Articles
-
Nanostructured Systems for the Organelle-specific Delivery of Anticancer Drugs
Mini-Reviews in Medicinal Chemistry The Ayurvedic Bhasma: The Ancient Science of Nanomedicine
Recent Patents on Nanomedicine Capillary Electrophoresis with Mass Spectrometry: Applications to Metabolomic Analysis
Current Metabolomics Building Better Chimeric Antigen Receptors for Adoptive T Cell Therapy
Current Gene Therapy Inhibition of Apoptosis in Pediatric Cancer by Survivin
Current Pediatric Reviews Innovative Drug Delivery Systems for the Administration of Natural Compounds
Current Bioactive Compounds CD147/EMMPRIN and CD44 are Potential Therapeutic Targets for Metastatic Prostate Cancer
Current Cancer Drug Targets Editorial [Hot topic: Bisphosphonates and Bone Diseases: Past, Present and Future (Guest Editor: Dominique HEYMANN)]
Current Pharmaceutical Design Lentiviral-Mediated Beclin-1 Overexpression Inhibits Cell Proliferation and Induces Autophagy of Human Esophageal Carcinoma Eca109 Cell Xenograft in Nude Mice
Recent Patents on Anti-Cancer Drug Discovery An Overview of Phytotherapeutic Approaches for the Treatment of Benign Prostatic Hyperplasia
Mini-Reviews in Medicinal Chemistry Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches
Current Topics in Medicinal Chemistry subject Index To Volume 2
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Quantitative Analysis and Pharmacokinetics Study of Integrin Antagonist AP25 in Rat Plasma
Protein & Peptide Letters Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance
Current Medicinal Chemistry Nuclear Hormone Receptors and Female Reproduction
Current Molecular Medicine In Silico Study of Chromatographic Lipophilicity Parameters of 3-(4-Substituted Benzyl)-5-Phenylhydantoins
Combinatorial Chemistry & High Throughput Screening Proteoglycan Involvement in Inflammatory Diseases. New Developments in GAG-Based Therapies
Medicinal Chemistry Reviews - Online (Discontinued) Bursal Hexapeptide, A Potential Immunomodulator, Inhibits Tumor Cells Proliferation via p53 Signaling Pathway
Anti-Cancer Agents in Medicinal Chemistry Onset Age and Clinical Heterogeneity of Dementias: A Diagnostic and Therapeutic Approach
Current Psychopharmacology Use of Thiazolidinediones and Risk of Bladder Cancer: Disease or Drugs?
Current Drug Safety